"Thymus Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the THYMUS GLAND.
Descriptor ID |
D013953
|
MeSH Number(s) |
C04.588.894.949 C15.604.861
|
Concept/Terms |
Thymus Neoplasms- Thymus Neoplasms
- Neoplasm, Thymus
- Thymus Neoplasm
- Thymus Tumors
- Thymus Tumor
- Tumor, Thymus
- Tumors, Thymus
- Thymic Neoplasms
- Thymic Tumors
- Thymic Tumor
- Tumor, Thymic
- Tumors, Thymic
- Neoplasms, Thymic
- Neoplasm, Thymic
- Thymic Neoplasm
- Neoplasms, Thymus
Cancer of Thymus- Cancer of Thymus
- Thymus Cancers
- Thymic Cancer
- Cancer, Thymic
- Cancers, Thymic
- Thymic Cancers
- Thymus Cancer
- Cancer, Thymus
- Cancers, Thymus
- Cancer of the Thymus
|
Below are MeSH descriptors whose meaning is more general than "Thymus Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Thymus Neoplasms".
This graph shows the total number of publications written about "Thymus Neoplasms" by people in this website by year, and whether "Thymus Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 3 | 0 | 3 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thymus Neoplasms" by people in Profiles.
-
Antimetabolic Agent 3-Bromopyruvate Exerts Myelopotentiating Action in a Murine Host Bearing a Progressively Growing Ascitic Thymoma. Immunol Invest. 2020 May; 49(4):425-442.
-
Cytotoxic action of acetate on tumor cells of thymic origin: Role of MCT-1, pH homeostasis and altered cell survival regulation. Biochimie. 2019 Feb; 157:1-9.
-
Cytologic findings of spindle epithelial tumor with thymus-like elements. Laryngoscope. 2018 02; 128(2):E78-E82.
-
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014 Sep; 9(9 Suppl 2):S81-7.
-
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014 Sep; 9(9 Suppl 2):S73-80.
-
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014 Sep; 9(9 Suppl 2):S65-72.
-
The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol. 2013 Dec; 8(12):1467-73.
-
Multi-step lymphomagenesis deduced from DNA changes in thymic lymphomas and atrophic thymuses at various times after gamma-irradiation. Oncogene. 2007 Aug 09; 26(36):5280-9.
-
53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. Proc Natl Acad Sci U S A. 2006 Feb 28; 103(9):3310-5.
-
[ADRENAL HYPERCORTICISM AND THYMIC CANCER]. Presse Med. 1965 Jun 23; 73:1831-4.